Tong X, Yuan Z, Lei Y
J Cosmet Dermatol. 2025; 24(2):e70032.
PMID: 39936293
PMC: 11815537.
DOI: 10.1111/jocd.70032.
Seidel P, Bohm M
Dermatologie (Heidelb). 2025; 76(3):168-178.
PMID: 39904778
DOI: 10.1007/s00105-024-05467-9.
Xie Y, Shi W, Yin W, Mei X
J Cosmet Dermatol. 2024; 24(2):e16715.
PMID: 39645646
PMC: 11845925.
DOI: 10.1111/jocd.16715.
Tharwat S, Hamdy F, Hamdy S, Nassar M
BMC Rheumatol. 2024; 8(1):59.
PMID: 39501366
PMC: 11539671.
DOI: 10.1186/s41927-024-00427-1.
Yang R, Chen S, Fu S, Zhao D, Wan W, Yang K
Front Cell Dev Biol. 2024; 11:1293101.
PMID: 38178870
PMC: 10764575.
DOI: 10.3389/fcell.2023.1293101.
A Systematic Study of Yiqi Qubai Standard Decoction for Treating Vitiligo Based on UPLC-Q-TOF/MS Combined with Chemometrics, Molecular Docking, and Cellular and Zebrafish Assays.
Cui L, Ma C, Shi W, Yang C, Wu J, Wu Z
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139842
PMC: 10747336.
DOI: 10.3390/ph16121716.
Vitiligo: Pathogenesis and New and Emerging Treatments.
Perez-Bootello J, Cova-Martin R, Naharro-Rodriguez J, Segurado-Miravalles G
Int J Mol Sci. 2023; 24(24).
PMID: 38139134
PMC: 10743634.
DOI: 10.3390/ijms242417306.
Real-World Treatment Patterns in Patients with Vitiligo in the United States.
Rosmarin D, Soliman A, Li C
Dermatol Ther (Heidelb). 2023; 13(9):2079-2091.
PMID: 37548877
PMC: 10442304.
DOI: 10.1007/s13555-023-00983-3.
Visualization of Phototherapy Evolution by Optical Imaging.
Li Z, Li Z, Wang J
Molecules. 2023; 28(10).
PMID: 37241733
PMC: 10223045.
DOI: 10.3390/molecules28103992.
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.
Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M
Int J Mol Sci. 2023; 24(5).
PMID: 36902341
PMC: 10003418.
DOI: 10.3390/ijms24054910.
Recently FDA-approved drug: A new hope for vitiligo patients?.
Siddiq M, Obaid M, Zaidi S, Azam S, Rangwala B
Ann Med Surg (Lond). 2022; 82:104626.
PMID: 36268369
PMC: 9577636.
DOI: 10.1016/j.amsu.2022.104626.
FDA approves Ruxolitinib (Opzelura) for Vitiligo Therapy: A breakthrough in the field of dermatology.
Sheikh A, Rafique W, Owais R, Malik F, Ali E
Ann Med Surg (Lond). 2022; 81:104499.
PMID: 36147080
PMC: 9486756.
DOI: 10.1016/j.amsu.2022.104499.
Advances in vitiligo: Update on therapeutic targets.
Feng Y, Lu Y
Front Immunol. 2022; 13:986918.
PMID: 36119071
PMC: 9471423.
DOI: 10.3389/fimmu.2022.986918.
Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo.
Chen J, Yu N, Li H, Tang Y, Zhu H
J Int Med Res. 2022; 50(9):3000605221119646.
PMID: 36062405
PMC: 9446466.
DOI: 10.1177/03000605221119646.
A Literature Review Investigating the Use of Topical Janus Kinase Inhibitors for the Treatment of Vitiligo.
White C, Miller R
J Clin Aesthet Dermatol. 2022; 15(4):20-25.
PMID: 35465035
PMC: 9017670.
An overview of the efficacy of phototherapy in oncodermatology.
Park C, Korman A, Dulmage B
Support Care Cancer. 2022; 30(7):5591-5600.
PMID: 35107598
DOI: 10.1007/s00520-022-06841-w.
Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction.
Lagos K, Buzza H, Bagnato V, Romero M
Int J Mol Sci. 2022; 23(1).
PMID: 35008458
PMC: 8744821.
DOI: 10.3390/ijms23010022.
Vitiligo: What's old, what's new.
Bertolani M, Rodighiero E, de Felici Del Giudice M, Lotti T, Feliciani C, Satolli F
Dermatol Reports. 2021; 13(2):9142.
PMID: 34659674
PMC: 8451070.
DOI: 10.4081/dr.2021.9142.
Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.
Wang Y, Li S, Li C
Clin Rev Allergy Immunol. 2021; 61(3):299-323.
PMID: 34283349
DOI: 10.1007/s12016-021-08868-z.
Vitiligo and chronic autoimmune thyroiditis.
Sandru F, Carsote M, Albu S, Dumitrascu M, Valea A
J Med Life. 2021; 14(2):127-130.
PMID: 34104234
PMC: 8169145.
DOI: 10.25122/jml-2019-0134.